The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval ...

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

Writing in JAMA, four former government officials warn that the Trump administration’s involvement in delaying the approval ...

This is what it looks like when disinformation doctors pretend to value data and science to further their true objective, ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Three simultaneous withdrawals—from the World Health Organization, USAID and the Gavi vaccine alliance—represent a ...

Novavax (NVAX) closed at $6.36 in the latest trading session, marking a -2.15% move from the prior day. This move lagged the ...

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review standards.

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...